UK:CO:VACCITECH
Vaccitech
- Stock
Last Close
4.49
06/11 21:00
Market Cap
192.73M
Beta: -
Volume Today
163.05K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | |||||
average payables | 4.28M - | 3.54M 17.18% | 3.08M 12.96% | ||
average receivables | 3.57M - | 4.74M 32.82% | 8.32M 75.59% | ||
book value per share | -782.91 - | 9.74 101.24% | 6.52 33.03% | ||
capex per share | -6.14 - | -0.04 99.28% | -0.16 272.34% | ||
capex to depreciation | -1.40 - | -1.90 35.50% | -1.42 25.41% | ||
capex to operating cash flow | 0.03 - | 0.04 32.49% | 0.43 1,109.31% | ||
capex to revenue | -0.06 - | -4.28 6,940.34% | -0.14 96.79% | ||
cash per share | 908.07 - | 8.27 99.09% | 5.22 36.87% | ||
days of inventory on hand | |||||
days payables outstanding | |||||
days sales outstanding | 244.29 - | 8.51K 3,383.89% | 84.82 99.00% | ||
debt to assets | 0.09 - | 0.92 880.24% | 0.03 97.19% | 0.03 26.20% | |
debt to equity | -0.08 - | -1.24 1,469.33% | 0.03 102.30% | 0.04 26.09% | |
dividend yield | |||||
earnings yield | -26.69 - | -0.18 99.33% | 0.06 134.35% | ||
enterprise value | -9.65M - | 3.77M 139.06% | 80.85M 2,044.38% | -98.08M 221.30% | |
enterprise value over ebitda | -0.23 - | -1.98 766.32% | -112.86 5,607.24% | ||
ev to operating cash flow | -0.34 - | -2.48 625.80% | 6.80 373.88% | ||
ev to sales | 0.78 - | 301.70 38,468.87% | -2.19 100.73% | ||
free cash flow per share | -237.61 - | -1.30 99.45% | -0.55 57.61% | ||
free cash flow yield | -16.85 - | -0.12 99.30% | -0.23 100.43% | ||
graham net net | -879.24 - | 7.36 100.84% | 4.70 36.10% | ||
graham number | 2.57K - | 20.79 99.19% | 4.59 77.94% | ||
income quality | 0.61 - | 0.64 3.66% | -2.71 525.44% | ||
intangibles to total assets | 0 - | 0 | 0.16 Infinity% | 0.15 4.56% | |
interest coverage | -5.57 - | -16.95 204.35% | -181.79 972.54% | ||
interest debt per share | 1.05K - | 0.38 99.96% | 0.24 38.20% | ||
inventory turnover | |||||
invested capital | -0.08 - | -1.24 1,469.33% | 0.03 102.30% | 0.04 26.09% | |
market cap | 671.81K - | 287.69M 42,722.69% | 87.53M 69.57% | ||
net current asset value | -24.87M - | -39.68M 59.52% | 198.61M 600.58% | 186.04M 6.33% | |
net debt to ebitda | -0.19 - | 5.06 2,796.57% | -213.59 4,322.24% | ||
net income per share | -376.39 - | -1.97 99.48% | 0.14 107.27% | ||
operating cash flow per share | -231.46 - | -1.26 99.46% | -0.39 69.21% | ||
payables turnover | |||||
receivables turnover | 1.49 - | 0.04 97.13% | 4.30 9,934.15% | ||
research and ddevelopement to revenue | 2.30 - | 61.08 2,550.70% | 0.92 98.49% | ||
return on tangible assets | -0.35 - | -0.22 38.98% | 0.02 110.77% | ||
revenue per share | 101.17 - | 0.01 99.99% | 1.20 11,495.86% | ||
roe | 0.48 - | -0.20 142.17% | 0.02 110.85% | ||
roic | -1.88 - | -0.17 90.97% | -0.08 51.06% | ||
sales general and administrative to revenue | 2.17 - | 93.72 4,210.53% | 0.14 99.85% | ||
shareholders equity per share | -782.91 - | 9.74 101.24% | 6.52 33.03% | ||
stock based compensation to revenue | 0.75 - | 61.52 8,080.60% | 0.22 99.64% | ||
tangible asset value | -22.08M - | -36.91M 67.18% | 208.50M 664.87% | 202.72M 2.77% | |
tangible book value per share | -774.71 - | 8.05 101.04% | 5.44 32.41% | ||
working capital | 10.50M - | 40.26M 283.53% | 215.61M 435.53% | 200.80M 6.87% |
All numbers in (except ratios and percentages)